Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94)

Bourhis, 2006, Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis, Lancet, 368, 843, 10.1016/S0140-6736(06)69121-6 Pignon, 2009, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients, Radiother Oncol, 92, 4, 10.1016/j.radonc.2009.04.014 Brun, 2002, FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma, Head Neck, 24, 127, 10.1002/hed.10037 Hentschel, 2011, Early FDG PET at 10 or 20Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer, Eur J Nucl Med Mol Imaging, 38, 1203, 10.1007/s00259-011-1759-3 Jaulerry, 1995, Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study, Int J Radiat Oncol Biol Phys, 33, 271, 10.1016/0360-3016(95)00157-T Ghadjar, 2011, Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94), Int J Radiat Oncol Biol Phys, 82, 524, 10.1016/j.ijrobp.2010.11.067 Corvò, 1996, Cell kinetics and tumor regression during radiotherapy in head and neck squamous-cell carcinomas, Int J Cancer, 68, 151, 10.1002/(SICI)1097-0215(19961009)68:2<151::AID-IJC1>3.0.CO;2-X Ceulemans, 2011, Can 18-FDG-PET during radiotherapy replace post-therapy scanning for detection/demonstration of tumor response in head-and-neck cancer?, Int J Radiat Oncol Biol Phys, 81, 938, 10.1016/j.ijrobp.2010.07.019 Thiagarajan, 2012, Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination, Int J Radiat Oncol Biol Phys, 83, 220, 10.1016/j.ijrobp.2011.05.060